Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: Prognostic implications.

Bolzoni Villaret A, Barbieri D, Peretti G, Schreiber A, Fisogni S, Lonardi S, Facchetti F, Nicolai P.

Head Neck. 2013 Aug;35(8):1132-7. doi: 10.1002/hed.23097. Epub 2012 Aug 21.

PMID:
22907864
2.

Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications.

Bolzoni Villaret A, Schreiber A, Facchetti F, Fisogni S, Lonardi S, Lombardi D, Cocco D, Redaelli de Zinis LO, Nicolai P.

Head Neck. 2010 Jun;32(6):786-92. doi: 10.1002/hed.21256.

PMID:
19890908
3.

Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients.

Garcia-Carracedo D, Rodrigo JP, Astudillo A, Nieto CS, Gonzalez MV.

BMC Cancer. 2010 Aug 10;10:416. doi: 10.1186/1471-2407-10-416.

4.

Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.

Lin JY, Li XY, Dong P, Nakashima T.

J Laryngol Otol. 2011 Sep;125(9):945-51. doi: 10.1017/S0022215111001514. Epub 2011 Jul 21.

PMID:
21774849
5.

Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.

Laryngoscope. 2001 Jun;111(6):1079-87.

PMID:
11404625
6.

[Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].

Zou JD, Fu HY, Xu W, Lü ZH, Cao HY, Luan XY.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):461-4. Chinese.

PMID:
21875489
7.

Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients.

Anagnostou VK, Tiniakos DG, Fotinou M, Achimastos A, Syrigos KN.

Virchows Arch. 2011 Mar;458(3):331-40. doi: 10.1007/s00428-010-1015-4. Epub 2010 Dec 14.

PMID:
21161269
8.

Predictors of local failure in early laryngeal cancer.

Lohynska R, Slavicek A, Bahanan A, Novakova P.

Neoplasma. 2005;52(6):483-8.

PMID:
16284693
9.

Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.

Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M.

Strahlenther Onkol. 2004 Feb;180(2):84-90.

PMID:
14762660
10.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
11.

Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.

Marioni G, Marino F, Blandamura S, D'Alessandro E, Giacomelli L, Guzzardo V, Lionello M, De Filippis C, Staffieri A.

Histopathology. 2010 Oct;57(4):535-43. doi: 10.1111/j.1365-2559.2010.03664.x.

PMID:
20955379
12.

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, Haensgen G.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):778-87.

PMID:
12788185
13.

[Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].

Rübe C, Micke O, Grevers G, Rohloff R, Kaufmann H, Busch M, Willich N.

Strahlenther Onkol. 1997 Feb;173(2):83-90. German.

PMID:
9072844
14.

The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.

Kalfert D, Celakovsky P, Laco J, Ludvikova M.

Pathol Oncol Res. 2014 Oct;20(4):909-15. doi: 10.1007/s12253-014-9773-y. Epub 2014 Apr 24.

PMID:
24760498
15.
16.

Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.

Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR, Perez CA.

Head Neck. 1999 Dec;21(8):707-17.

PMID:
10562683
17.

Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.

Suzuki G, Yamazaki H, Ogo E, Abe T, Hayabuchi N, Umeno H, Nakashima T, Nakamura S, Yoshida K.

Anticancer Res. 2014 Jan;34(1):203-7.

PMID:
24403463
18.

Management of T3N1 glottic carcinoma: therapeutic outcomes.

Spector JG, Sessions DG, Lenox J, Simpson J.

Laryngoscope. 2006 Jan;116(1):106-10.

PMID:
16481820
19.

Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.

Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM.

Laryngoscope. 2000 Jun;110(6):1012-7.

PMID:
10852523
20.
Items per page

Supplemental Content

Write to the Help Desk